Lobbying Filing Details
Total Spending
$50,000
Activities
2
Lobbyists
5
Gov't Entities
4
Filing Information
- Filing UUID:
6f0e1c33-eb2c-4664-9bfe-75980c5e04b4- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2014 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 17, 2014 at 6:29 PM
- Income:
- $50,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: James "J.D." Derderian, President
Registrant
STANTON PARK GROUP
government affairs
Annapolis, MarylandClient
MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
Texas, United States of AmericaLobbying Activities (2)
Activity 1
Medicare/MedicaidMedicare, oncology, Radiation and Imaging Reimbursement issues; medicare physician payments; Health Information Technology; application of the sequester to cancer drug reimbursement (H.R.1416, the Cancer Patient Protection Act of 2013); prompt pay discount (HR 800 Prompt Pay Discount Legislation); safety and security of the prescription drug supply chain
Lobbyists (5)
- ERIN STRAWN
- VALERIE HENRY
- JAMES DERDERIAN
- PATRICK LYDEN
- MR. RICHARD MATHER RUSSELL
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
PharmacyPharmacy issues, prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug
abuse and diversion. H.R. 1919 "Safeguarding America's Pharmaceuticals Act of 2013". S. 957 "Drug Supply Chain Security Act".
S. 959 "Pharmaceutical Quality, Security and Accountability Act"
Lobbyists (5)
- ERIN STRAWN
- VALERIE HENRY
- JAMES DERDERIAN
- PATRICK LYDEN
- MR. RICHARD MATHER RUSSELL
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES